JBJuergen Brosius

Juergen Brosius

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Juergen Brosius has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander Hüttenhofer

    Institut fur Experimentelle|Laboratoire de Biologie Moleculaire|Universite Paul-Sabatier

    1 shared publication
  • Beicheng Sun

    Department of Hepatobiliary Surgery The Affiliated Drum Tower Hospital of Nanjing University Medical School China

    1 shared publication
  • Boris V. Skryabin

    Medical Faculty, Core Facility Transgenic Animal and Genetic Engineering Models (TRAM), University of Muenster, Von-Esmarch-Str. 56, 48149 Muenster, Germany

    1 shared publication
  • Cheng Deng

    Department of Respiratory and Critical Care Medicine, Center for High Altitude Medicine, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Delf-Magnus Kummerfeld

    Medical Faculty, Core Facility Transgenic Animal and Genetic Engineering Models (TRAM), University of Muenster, Von-Esmarch-Str. 56, 48149 Muenster, Germany

    1 shared publication
  • Fang Liu

    Jiangsu Key Laboratory for Biodiversity and Biotechnology College of Life Sciences Nanjing Normal University China

    1 shared publication

Latest Publications

  • Open Access

    Reference Genes across Nine Brain Areas of Wild Type and Prader-Willi Syndrome Mice: Assessing Differences in Igfbp7, Pcsk1, Nhlh2 and Nlgn3 Expression

    by Delf-Magnus Kummerfeld, Boris V. Skryabin, Juergen Brosius, Sergey Y. Vakhrushev, Timofey S. Rozhdestvensky

    Prader–Willi syndrome (PWS) is a complex neurodevelopmental disorder caused by the deletion or inactivation of paternally expressed imprinted genes at the chromosomal region 15q11–q13. The PWS-critical region (PWScr) harbors tandemly repeated non-protein coding IPW-A exons hosting the intronic SNORD116 snoRNA gene array that is predominantly expressed in brain. Paternal deletion of PWScr is associated with key PWS symptoms in humans and growth retardation in mice (PWScr model). Dysregulation of the hypothalamic–pituitary axis (HPA) is thought to be causally involved in the PWS phenotype. Here we performed a comprehensive reverse transcription quantitative PCR (RT-qPCR) analysis across nine different brain regions of wild-type (WT) and PWScr mice to identify stably expressed reference genes. Four methods (Delta Ct, BestKeeper, Normfinder and Genorm) were applied to rank 11 selected reference gene candidates according to their expression stability. The resulting panel consists of the top three most stably expressed genes suitable for gene-expression profiling and comparative transcriptome analysis of WT and/or PWScr mouse brain regions. Using these reference genes, we revealed significant differences in the expression patterns of Igfbp7, Nlgn3 and three HPA associated genes: Pcsk1, Pcsk2 and Nhlh2 across investigated brain regions of wild-type and PWScr mice. Our results raise a reasonable doubt on the involvement of the Snord116 in posttranscriptional regulation of Nlgn3 and Nhlh2 genes. We provide a valuable tool for expression analysis of specific genes across different areas of the mouse brain and for comparative investigation of PWScr mouse models to discover and verify different regulatory pathways affecting this complex disorder.


  • Open Access

    Constitutive activity of GPR26 regulated by ubiquitin‐dependent degradation and its antitumor role

    by Fang Liu, Wei Yang, Minghui Hu, Yong Zhang, Beicheng Sun, Hao Yang, Juergen Brosius, Cheng Deng

    G protein‐coupled receptors (GPCRs) play important roles in many physiological functions and numerous diseases. In addition to the classic ligand‐stimulated receptor activity, an increasing number of studies have established that many GPCRs function constitutively in a receptor dose‐dependent manner. Previous observations showed that following gene transfection, little or no protein was detectable for certain GPCRs (designated apparent state A), such as GPR26, GPR39, GPR78, GPR133, GPR139, BRS3, and LGR5, which showed strong constitutive activities. When we lysed cells in the immediate presence of western blot loading buffer, a significant increase of protein levels was detected (actual state B), which was much closer to the true expression levels under physiological conditions. GPR26 was chosen for further functional experiments as the actual state B. We identified an important ubiquitination site, K286, as well as the ubiquitin ligase E3 homologous to the E6‐associated protein carboxyl terminus domain containing 3 interacting with GPR26. The pronounced differences in the protein expression and constitutive activity of GPR26 were a consequence of the ubiquitin‐mediated rapid degradation mechanism. Furthermore, we identified in vitro and in vivo antitumor activity associated with high expression levels and constitutive activity of GPR26 in liver cancer cells. Hence, GPR26 could act as an antitumor gene for hepatocellular carcinoma. This study also represents the actual state B of a batch of GPCRs that actually play potentially important roles in physiological functions by their constitutive activity, which is controlled by rapid ubiquitin‐dependent degradation.


  • Open Access

    RNomics: an experimental approach that identifies 201 candidates for novel, small, non‐messenger RNAs in mouse

    by Alexander Hüttenhofer, Martin Kiefmann, Sebastian Meier‐Ewert, John O'BRien, Hans Lehrach, Jean‐Pierre Bachellerie, Jürgen Brosius

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.